UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

High-cocoa polyphenol-rich chocolate improves HDL cholesterol in Type 2 diabetes patients

Diabetic medicine, 2010-11, Vol.27 (11), p.1318-1321

2010

Volltextzugriff (PDF)

Recent advances in cardiovascular aspects of polycystic ovary syndrome

European journal of endocrinology, 2012-04, Vol.166 (4), p.575

2012

Volltextzugriff (PDF)

Relating mean blood glucose and glucose variability to the risk of multiple episodes of hypoglycaemia in type 1 diabetes

Diabetologia, 2007-12, Vol.50 (12), p.2553-2561

2007

Volltextzugriff (PDF)

Glucagon-like peptide-1 analogue, liraglutide, improves liver fibrosis markers in obese women with polycystic ovary syndrome and nonalcoholic fatty liver disease

Clinical endocrinology (Oxford), 2014-10, Vol.81 (4), p.523-528

2014

Volltextzugriff (PDF)

High-polyphenol chocolate reduces endothelial dysfunction and oxidative stress during acute transient hyperglycaemia in Type 2 diabetes: a pilot randomized controlled trial

Diabetic medicine, 2013-04, Vol.30 (4), p.478-483

2013

Volltextzugriff (PDF)

Primary Medical Therapy for Acromegaly: An Open, Prospective, Multicenter Study of the Effects of Subcutaneous and Intramuscular Slow-Release Octreotide on Growth Hormone, Insulin-Like Growth Factor-I, and Tumor Size

The journal of clinical endocrinology and metabolism, 2002-10, Vol.87 (10), p.4554-4563

2002

Volltextzugriff (PDF)

Mean blood glucose compared with HbA1c in the prediction of cardiovascular disease in patients with type 1 diabetes

Diabetologia, 2008-02, Vol.51 (2), p.365-371

2008

Volltextzugriff (PDF)

The effect of atorvastatin and simvastatin on vitamin D, oxidative stress and inflammatory marker concentrations in patients with type 2 diabetes: a crossover study

Diabetes, obesity & metabolism, 2013-08, Vol.15 (8), p.767-769

2013

Volltextzugriff (PDF)

Glucose variability does not contribute to the development of peripheral and autonomic neuropathy in type 1 diabetes: data from the DCCT

Diabetologia, 2009-10, Vol.52 (10), p.2229-2232

2009

Volltextzugriff (PDF)

Somatostatin receptors 2 and 5 are preferentially expressed in proliferating endothelium

British journal of cancer, 2005-04, Vol.92 (8), p.1493-1498

2005

Volltextzugriff (PDF)

The effect of extensive flooding in Hull on the glycaemic control of patients with diabetes

Diabetic medicine, 2011-05, Vol.28 (5), p.519-524

2011

Volltextzugriff (PDF)

Orlistat Is as Beneficial as Metformin in the Treatment of Polycystic Ovarian Syndrome

The journal of clinical endocrinology and metabolism, 2005-02, Vol.90 (2), p.729-733

2005

Volltextzugriff (PDF)

Does severe hypoglycaemia influence microvascular complications in Type 1 diabetes? An analysis of the Diabetes Control and Complications Trial database

Diabetic medicine, 2012-09, Vol.29 (9), p.1195-1198

2012

Volltextzugriff (PDF)

Effect of metformin, orlistat and pioglitazone treatment on mean insulin resistance and its biological variability in polycystic ovary syndrome

Clinical endocrinology (Oxford), 2009-02, Vol.70 (2), p.233-237

2009

Volltextzugriff (PDF)

Biological variation of cardiovascular risk factors in patients with diabetes

Diabetic medicine, 2013-10, Vol.30 (10), p.1172-1180

2013

Volltextzugriff (PDF)

Implications of new European Union driving regulations on patients with Type 1 diabetes who participated in the Diabetes Control and Complications Trial

Diabetic medicine, 2013-05, Vol.30 (5), p.616-619

2013

Volltextzugriff (PDF)

Insulin resistance and free androgen index correlate with the outcome of controlled ovarian hyperstimulation in non-PCOS women undergoing IVF

Human reproduction (Oxford), 2010-02, Vol.25 (2), p.504-509

2010

Volltextzugriff (PDF)

Polycystic ovary syndrome has no independent effect on vascular, inflammatory or thrombotic markers when matched for obesity

Clinical endocrinology (Oxford), 2013-08, Vol.79 (2), p.252-258

2013

Volltextzugriff (PDF)

Elevated glycated haemoglobin is a strong predictor of mortality in patients with left ventricular systolic dysfunction who are not receiving treatment for diabetes mellitus

Heart (British Cardiac Society), 2009-06, Vol.95 (11), p.917-923

2009

Volltextzugriff (PDF)

Use of complementary markers in assessing glycaemic control in people with diabetic kidney disease undergoing iron or erythropoietin treatment

Diabetic medicine, 2013-10, Vol.30 (10), p.1250-1254

2013

Volltextzugriff (PDF)

Effects of human recombinant growth hormone on exercise capacity, cardiac structure, and cardiac function in patients with adult-onset growth hormone deficiency

Journal of international medical research, 2017-12, Vol.45 (6), p.1708-1719

2017

Volltextzugriff (PDF)

The Biological Variation of Testosterone and Sex Hormone-Binding Globulin (SHBG) in Polycystic Ovarian Syndrome: Implications for SHBG as a Surrogate Marker of Insulin Resistance

The journal of clinical endocrinology and metabolism, 2003-04, Vol.88 (4), p.1528-1533

2003

Volltextzugriff (PDF)

Endocrine disruptor & nutritional effects of heavy metals in ovarian hyperstimulation

Journal of assisted reproduction and genetics, 2011-12, Vol.28 (12), p.1223-1228

2011

Volltextzugriff (PDF)

Increased expression of circulating miRNA-93 in women with polycystic ovary syndrome may represent a novel, non-invasive biomarker for diagnosis

Scientific reports, 2015-11, Vol.5 (1), p.16890-16890, Article 16890

2015

Volltextzugriff (PDF)

Soy isoflavones improve cardiovascular disease risk markers in women during the early menopause

Nutrition, metabolism, and cardiovascular diseases, 2018-07, Vol.28 (7), p.691-697

2018

Volltextzugriff (PDF)

1 – 25 von 1.556

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.388)
Mit Volltextzugriff
(1.329)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

2 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(1.050)
Life Sciences & Biomedicine
(755)
Humans
(623)
Female
(421)
Male
(299)
Adult
(260)
Middle Aged
(217)
Endocrinology & Metabolism
(208)
Biological And Medical Sciences
(199)
Diabetes
(195)
Science & Technology - Other Topics
(173)
Multidisciplinary Sciences
(165)
Medical Sciences
(153)
Diabetes Mellitus
(144)
Physical Sciences
(142)
Aged
(137)
Insulin Resistance
(112)
Glucose
(111)
Risk Factors
(111)
Insulin
(100)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Plos One
(132)
Clinical Endocrinology
(40)
Frontiers In Endocrinology
(34)
Diabetes Care
(28)
Diabetic Medicine
(22)
Scientific Reports
(22)
International Journal Of Endocrinology
(18)
Journal Of Cellular Physiology
(18)
Bmj
(17)
The Journal Of Clinical Endocrinology And Metabolism
(17)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

High-cocoa polyphenol-rich chocolate improves HDL cholesterol in Type 2 diabetes patients

Recent advances in cardiovascular aspects of polycystic ovary syndrome

Relating mean blood glucose and glucose variability to the risk of multiple episodes of hypoglycaemia in type 1 diabetes

Glucagon-like peptide-1 analogue, liraglutide, improves liver fibrosis markers in obese women with polycystic ovary syndrome and nonalcoholic fatty liver disease

High-polyphenol chocolate reduces endothelial dysfunction and oxidative stress during acute transient hyperglycaemia in Type 2 diabetes: a pilot randomized controlled trial

Primary Medical Therapy for Acromegaly: An Open, Prospective, Multicenter Study of the Effects of Subcutaneous and Intramuscular Slow-Release Octreotide on Growth Hormone, Insulin-Like Growth Factor-I, and Tumor Size

Mean blood glucose compared with HbA1c in the prediction of cardiovascular disease in patients with type 1 diabetes

The effect of atorvastatin and simvastatin on vitamin D, oxidative stress and inflammatory marker concentrations in patients with type 2 diabetes: a crossover study

Glucose variability does not contribute to the development of peripheral and autonomic neuropathy in type 1 diabetes: data from the DCCT

Somatostatin receptors 2 and 5 are preferentially expressed in proliferating endothelium

The effect of extensive flooding in Hull on the glycaemic control of patients with diabetes

Orlistat Is as Beneficial as Metformin in the Treatment of Polycystic Ovarian Syndrome

Does severe hypoglycaemia influence microvascular complications in Type 1 diabetes? An analysis of the Diabetes Control and Complications Trial database

Effect of metformin, orlistat and pioglitazone treatment on mean insulin resistance and its biological variability in polycystic ovary syndrome

Biological variation of cardiovascular risk factors in patients with diabetes

Implications of new European Union driving regulations on patients with Type 1 diabetes who participated in the Diabetes Control and Complications Trial

Insulin resistance and free androgen index correlate with the outcome of controlled ovarian hyperstimulation in non-PCOS women undergoing IVF

Polycystic ovary syndrome has no independent effect on vascular, inflammatory or thrombotic markers when matched for obesity

Elevated glycated haemoglobin is a strong predictor of mortality in patients with left ventricular systolic dysfunction who are not receiving treatment for diabetes mellitus

Use of complementary markers in assessing glycaemic control in people with diabetic kidney disease undergoing iron or erythropoietin treatment

Effects of human recombinant growth hormone on exercise capacity, cardiac structure, and cardiac function in patients with adult-onset growth hormone deficiency

The Biological Variation of Testosterone and Sex Hormone-Binding Globulin (SHBG) in Polycystic Ovarian Syndrome: Implications for SHBG as a Surrogate Marker of Insulin Resistance

Endocrine disruptor & nutritional effects of heavy metals in ovarian hyperstimulation

Increased expression of circulating miRNA-93 in women with polycystic ovary syndrome may represent a novel, non-invasive biomarker for diagnosis

Soy isoflavones improve cardiovascular disease risk markers in women during the early menopause

Suchergebnisse filtern